Kayadiol decreases GSH in NKTCL cells and induces ferroptosis in NKTCL cells by inhibiting SLC7A11 and GPX4 expression through the upregulation of TP53. The gene discussed is GPX4; the disease is extranodal nasal NK/T cell lymphoma.